l-ornithine l-aspartate + silymarin (Atlina Lifesciences)

L-Corlina is a branded generic combination pharmaceutical product developed and marketed by Atlina Life Sciences, an Indian company focused on finished generic formulations. The drug is primarily indicated for the management of chronic liver diseases, including liver cirrhosis and hepatic encephalopathy. It contains two active components: l-ornithine l-aspartate (LOLA) and silymarin. LOLA is a stable salt of two amino acids that facilitates ammonia detoxification by providing substrates for the urea cycle in hepatocytes and glutamine synthesis in both the liver and brain. Silymarin, a flavonoid complex extracted from milk thistle (Silybum marianum), provides complementary hepatoprotective effects through its antioxidant activity, stabilization of hepatocyte membranes, and stimulation of ribosomal RNA synthesis, which aids in liver cell regeneration. As a branded generic, L-Corlina is marketed for retail and franchise distribution in the Indian pharmaceutical market.

Brand names

L-Corlina

Other names

L-CorlinaL-Ornithine L-Aspartate + SilymarinLOLA + Silymarin